BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Barclays upgrades Dr Reddy's Lab to overweight
Recent sell-off has been overdone. Margin concerns on R&D spend may be exaggerated. Domestic market & Pharmaceutical Services and Active Ingredients (PSAI) segment on recovery mode for FY15. Valuations turn attractive after correction.